Navigation Links
Pharma Elite to Unveil Latest Industry News/Program Agenda with 70+ Expert Speakers at Exclusive Event: Pharma CI Conference, September 13-14, 2011 in New Jersey
Date:5/11/2011

PARSIPPANY, N.J., May 11, 2011 /PRNewswire/ -- Pharmaceutical giants seeking new areas for innovation and getting the best and latest information on the pharma industry all know there's only way to do it right. They all leverage the most successful and time-tested event for pharma industry leaders- the Pharma CI Conference & Exhibition on Sept. 13-14, 2011 in Parsippany, New Jersey (www.pharmaciconference.com).

The just-announced program agenda boasts 70+ speakers and 50+ sessions! The impressive speaking faculty includes all the pharma leaders in competitive intelligence, with fascinating insight shared from prestigious companies like Pfizer, Merck, Johnson & Johnson, Bayer, Roche, Sanofi Aventis, Boehringer Ingelheim, Astellas Pharma, Genzyme, Millennium, Eisai, Bausch & Lomb, DSM, Cephalon, Quintiles, Genentech, and more (http://pharmaciconference.com/Speakers)!

The Pharma CI Conference is guided by superior leadership from conference chairpersons, Dr. Daniel Pascheles, Vice President, Head Global Competitive Intelligence, Merck, and Sue Ward, Senior Director, Worldwide Competitive Intelligence, Pfizer. Some agenda topics include the following:

Pharma 3.0 and the New Health Care Ecosystem
Pharm Baby Boomer Strategies
Identifying Competitive Advantage Through Learning from Adjacencies
Collecting Generic CI from India and China
Better Answers Start with Better KIQs
The Changing Role of Government in Healthcare
Challenges for CI in Rare Diseases
Using Competitive Intelligence to Improve Your Customer Insights (the Other CI)
How Europe is Potentially Influencing US Healthcare Policy
Emerging Markets Strategies
Social Media Monitoring:  Mining the Web for Maximum Value in the Pharmaceutical Industry
Biosimilars
Competition 2.0: Brands vs. Generics
Influencing the Regulatory E
'/>"/>

SOURCE Pharma CI Conference
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Medco Research Institute® and AssureRx Health Initiate Pilot Program to Evaluate Adoption and Clinical Impact of Pharmacogenetic Testing for Selection of Psychotropic Medications
2. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
3. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
4. China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results
5. Tourette Syndrome Association and Psyadon Pharmaceuticals to Collaborate on a Drug Trial for Tourette Syndrome Treatment
6. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
7. Reportlinker Adds Markets for Emerging Pharmaceutical Technologies
8. Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
9. PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015
10. WuXi PharmaTech Announces First-Quarter 2011 Results
11. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
(Date:5/20/2013)... GLENWOOD, Ill. , May 20, 2013 ... leader in personal and environmental radiation measurement and monitoring, ... accessories, announced today that its Board of Directors declared, ... quarterly cash dividend of $0.55 per share for the ... paid on July 3, 2013, to shareholders of record ...
(Date:5/20/2013)... , May 20, 2013   National Community Pharmacists ... , RPh, MBA issued the following statement today ... regarding Medicare Part D "preferred pharmacy" drug plans ... patients the plan,s lowest advertised co-payments: (Logo:  ... Medicare and MedPAC , 16 U.S. ...
Breaking Medicine Technology:North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4Landauer, Inc. Declares Regular Cash Dividend 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4
... (Nasdaq CM: SPEX), an innovator in biotechnology for ... providers of technical and regulatory consulting services to ... that the Company,s pharmaceutical product, D-tagatose, has been ... promising cardiovascular/metabolic therapies in development.  The selection was ...
... a developer and manufacturer of ultrahigh-brightness light sources for ... a clean manufacturing facility at its Massachusetts location. The ... assembly capability that will be used for optics assembly ... "Our new clean manufacturing space will give ...
Cached Medicine Technology:Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 2Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 3Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development 4Energetiq Technology Implements Clean Manufacturing 2
(Date:5/21/2013)... Dimensional Insight, a developer of business intelligence ... Maryland Health System, a 275-bed hospital based in ... to help it analyze its data more quickly. Western ... Diver through Dimensional Insight’s recently announced partnership with ... Maryland has massive amounts of data in disparate systems, ...
(Date:5/21/2013)... AAG Health, the leading age management ... that it has acquired the OligoScan test made by ... advanced spectrophotometry technology, the OligoScan device is capable of ... 14 heavy metals, 20 trace elements (minerals), and oxidative ... substances such as mercury, lead, aluminum, and arsenic, will ...
(Date:5/21/2013)... ATS 2013, PHILADELPHIA The surgical management of non-small ... depending on the race of the patient, according to ... for Stage I and Stage II NSCLC is surgery," ... Medical Center in Omaha, Nebraska. "In our study of ... hospitals between the years 2000 and 2010, we found ...
(Date:5/21/2013)... After the success of its inaugural 1,000 ... Fit Body Boot Camp Goderich will be hosting its 2nd ... Goderich fitness center located at 199 Anglesea Street ... Challenge’s goal is to inspire and motivate local community residents ... The fee to participate is discounted to $40 for ...
(Date:5/21/2013)... Verdasys today announced availability ... (MSCD), a fully managed, outsourced service for companies ... malware and persistent cyber attacks from stealing sensitive data. ... data protection platform by making it available via a ... data transactions and systems events as well as data ...
Breaking Medicine News(10 mins):Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 2Health News:AAG Health is the First Age Management Center in Florida to Offer the OligoScan 3Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Goderich Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 2Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 3Health News:Verdasys Introduces New Managed Service for Cyber Threat Defense 4
... (NYSE: HB ) today announced its fiscal 2008 ... declared by Hillenbrand,s,Board of Directors on February 7, 2008, ... record at the close of business on March 17, ... is organized into two operating companies,serving the health care ...
... 6 times more likely to make mistakes , , FRIDAY, ... are about six times more likely to make medication errors ... a 123 pediatric residents at three children,s hospitals in the ... residents were depressed, and 74 percent were burned out. During ...
... CJPS Enterprises, LLC, (http://www.cjps-enterprises.com ) announced that it ... and licensing of intellectual property (IP)., The ... already,making its website available to universities, research organizations, ... "You have,to fill the shelves of the store ...
... Oversee Phase 3 Program of CGT-2168, ... Pharmaceuticals,Inc., today named a distinguished international panel ... Steering Committee charged with overseeing COGENT,the company,s ... its novel,combination antiplatelet product CGT-2168., (Logo: ...
... Mylan Inc. (NYSE: MYL ),today announced that Mylan ... judge in Florida finding that the inclusion of,Levothyroxine Sodium ... of legislative authority and that the product should be ... products available to pharmacies in Florida as soon,as motions ...
... MBF Healthcare,Acquisition Corp. (AMEX: MBH ), a ... it will host an investor,conference call on Friday, ... to,discuss the recently announced signing of a definitive ... (along with its,subsidiaries, "CHS"). Hosting the call from ...
Cached Medicine News:Health News:Depression in Young Doctors Tied to Medication Errors 2Health News:CJPS Enterprises Spins Off New Company for Intellectual Property Marketing 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 2Health News:Cogentus Pharmaceuticals Names Scientific Steering Committee for Global Phase 3 Clinical Program 3Health News:Mylan Restores Availability of Generic Levothyroxine in Florida 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 2Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 3Health News:MBF Healthcare Acquisition Corp. to Host Investor Conference Call to Review Stock Purchase Agreement Signed With Critical Homecare Solutions Holdings, Inc. 4
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... multi-drug test device provides clear, ... Negative results can be determined ... minutes; positive results require only ... urine sample application will dependably ...
... abuse tests are highly accurate in detecting the ... as confirmed by GC/MS testing. The assay provides ... method (such as GC/MS) must be used in ... should be applied to any drug of abuse ...
Medicine Products: